Center for Scientific Review; Notice of Closed Meeting, 771-772 [2019-00337]
Download as PDF
Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee 2019 Schedule
Office of the National
Coordinator for Health Information
Technology (ONC), HHS. ACTION: 2019
public meeting dates of the Health
Information Technology Advisory
Committee.
SUMMARY: The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with section 4003(e) of the 21st Century
Cures Act and the Federal Advisory
Committee Act. The HITAC, among
other things, identifies priorities for
standards adoption and makes
recommendations to the National
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings
throughout 2019. See list of public
meetings below.
FOR FURTHER INFORMATION CONTACT:
Lauren Richie, Designated Federal
Officer, at Lauren.Richie@hhs.gov.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
amozie on DSK3GDR082PROD with NOTICES1
AGENCY:
Composition
The HITAC is comprised of at least 25
members, of which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary;
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members will serve for one-, two-, or
three-year terms. All members may be
VerDate Sep<11>2014
20:21 Jan 30, 2019
Jkt 247001
reappointed for subsequent three-year
terms. Each member is limited to two
three-year terms, not to exceed six years
of service. After establishment, members
shall be appointed for a three-year term.
Members serve without pay, but will be
provided per-diem and travel costs for
committee services.
Recommendations
The HITAC recommendations to the
National Coordinator are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
Public Meetings
The schedule of meetings to be held
in 2019 is as follows:
• February 20, 2019 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time at the Omni Shoreham
Hotel, 2500 Calvert Street NW,
Washington, DC 20008.
• March 20, 2019 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time at
the Omni Shoreham Hotel, 2500 Calvert
Street NW, Washington, DC 20008.
• April 10, 2019 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time at
the Omni Shoreham Hotel, 2500 Calvert
Street NW, Washington, DC 20008.
• May 13, 2019 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting).
• June 19, 2019 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting).
• September 18, 2019 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time at the Omni Shoreham
Hotel, 2500 Calvert Street NW,
Washington, DC 20008.
• October 16, 2019 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting).
• November 13, 2019 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting).
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website, https://
www.healthit.gov/FACAS/calendar.
Contact Person for Meetings: Lauren
Richie, lauren.richie@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Lauren
Richie for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
PO 00000
Frm 00126
Fmt 4703
Sfmt 4703
771
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, and patient access. In addition,
the committee will also address any
administrative matters and hear
periodic reports from ONC. ONC
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ONC is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available at the location of the
advisory committee meeting, and the
background material will be posted on
ONC’s website after the meeting, at
https://www.healthit.gov/hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each presentation will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
Persons attending ONC’s HITAC
meetings are advised that the agency is
not responsible for providing wireless
access or access to electrical outlets.
ONC welcomes the attendance of the
public at its HITAC meetings. Seating is
limited at the location, and ONC will
make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Lauren Richie at least
seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. 92–463 , 5 U.S.C., App. 2).
Dated: January 15, 2019.
Lauren Richie,
Office of Policy, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 2019–00565 Filed 1–30–19; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\31JAN1.SGM
31JAN1
772
Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: February 12–13, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435–
1722, eissenstatma@csr.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 25, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00337 Filed 1–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
amozie on DSK3GDR082PROD with NOTICES1
Center for Scientific Review Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
VerDate Sep<11>2014
20:21 Jan 30, 2019
Jkt 247001
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Regulation, Learning
and Ethology Study Section.
Date: February 21–22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, md 20892, 301–
827–6830, unja.hayes@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00359 Filed 1–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Early
Psychosis Intervention Network (EPINET)
Review Meeting.
Date: February 21, 2019.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
PO 00000
Frm 00127
Fmt 4703
Sfmt 4703
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: January 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00354 Filed 1–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; DDK–B Conflicts.
Date: February 12–13, 2019.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\31JAN1.SGM
31JAN1
Agencies
[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Pages 771-772]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 772]]
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: February 12-13, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Michael Eissenstat, Ph.D., Scientific Review
Officer, BCMB IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD
20892, 301-435-1722, eissenstatma@csr.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 25, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00337 Filed 1-30-19; 8:45 am]
BILLING CODE 4140-01-P